請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/34217完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 于明暉(Ming-Whei Yu) | |
| dc.contributor.author | Ching-Fen Chuang | en |
| dc.contributor.author | 莊靜芬 | zh_TW |
| dc.date.accessioned | 2021-06-13T05:58:34Z | - |
| dc.date.available | 2007-07-31 | |
| dc.date.copyright | 2006-07-31 | |
| dc.date.issued | 2006 | |
| dc.date.submitted | 2006-06-27 | |
| dc.identifier.citation | 1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002;31:339-46. 3. Yu MW, Chen CJ. Epidemiologic characteristics and risk factors of hepatocellular carcinoma. J Natl Public Health Assoc 1992;11:155-187. 4. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis 1999;19:271-85. 5. Yu MW, You SL, Chang AS, Lu SN, Liaw YF, Chen CJ. Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res 1991;51:5621-5. 6. Yu MW, Chen CJ. Hepatitis B and C viruses in the development of hepatocellular carcinoma. Crit Rev Oncol Hematol 1994;17:71-91. 7. Yu MW, Yeh SH, Chen PJ, Liaw YF, Lin CL, Liu CJ, et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst 2005;97:265-72. 8. Ross RK, Yuan JM, Yu MC, Wogan GN, Qian GS, Tu JT, et al. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 1992;339:943-6. 9. Yu MC, Tong MJ, Govindarajan S, Henderson BE. Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. J Natl Cancer Inst 1991;83:1820-6. 10. Yu MW, Tsai SF, Hsu KH, You SL, Lee SS, Lin TM, et al. Epidemiologic characteristics of malignant neoplasms in Taiwan. II. Liver cancer. J Natl Public Health Assoc 1988;8:125-138. 11. Lok AS, Lai CL. Factors determining the development of hepatocellular carcinoma in hepatitis B surface antigen carriers. A comparison between families with clusters and solitary cases. Cancer 1988;61:1287-91. 12. Yu MW, Chang HC, Liaw YF, Lin SM, Lee SD, Liu CJ, et al. Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives. J Natl Cancer Inst 2000;92:1159-64. 13. Cai RL, Meng W, Lu HY, Lin WY, Jiang F, Shen FM. Segregation analysis of hepatocellular carcinoma in a moderately high-incidence area of East China. World J Gastroenterol 2003;9:2428-32. 14. Shen FM, Lee MK, Gong HM, Cai XQ, King MC. Complex segregation analysis of primary hepatocellular carcinoma in Chinese families: interaction of inherited susceptibility and hepatitis B viral infection. Am J Hum Genet 1991;49:88-93. 15. Yu MW, Chiu YH, Yang SY, Santella RM, Chern HD, Liaw YF, et al. Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers. Br J Cancer 1999;80:598-603. 16. Yu MW, Chiu YH, Chiang YC, Chen CH, Lee TH, Santella RM, et al. Plasma carotenoids, glutathione S-transferase M1 and T1 genetic polymorphisms, and risk of hepatocellular carcinoma: independent and interactive effects. Am J Epidemiol 1999;149:621-9. 17. Yu MW, Yang SY, Chiu YH, Chiang YC, Liaw YF, Chen CJ. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers. Hepatology 1999;29:697-702. 18. Chen CJ, Yu MW, Liaw YF, Wang LW, Chiamprasert S, Matin F, et al. Chronic hepatitis B carriers with null genotypes of glutathione S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma. Am J Hum Genet 1996;59:128-34. 19. Hsieh LL, Huang RC, Yu MW, Chen CJ, Liaw YF. L-myc, GST M1 genetic polymorphism and hepatocellular carcinoma risk among chronic hepatitis B carriers. Cancer Lett 1996;103:171-6. 20. Yu MW, Cheng SW, Lin MW, Yang SY, Liaw YF, Chang HC, et al. Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst 2000;92:2023-8. 21. Yu MW, Pai CI, Yang SY, Hsiao TJ, Chang HC, Lin SM, et al. Role of N-acetyltransferase polymorphisms in hepatitis B related hepatocellular carcinoma: impact of smoking on risk. Gut 2000;47:703-9. 22. Yu MW, Yang YC, Yang SY, Cheng SW, Liaw YF, Lin SM, et al. Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men. J Natl Cancer Inst 2001;93:1644-51. 23. Laurent-Puig P, Legoix P, Bluteau O, Belghiti J, Franco D, Binot F, et al. Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology 2001;120:1763-73. 24. Shih WL, Yu MW, Chen PJ, Yeh SH, Lo MT, Chang HC, et al. Localization of a susceptibility locus for hepatocellular carcinoma to chromosome 4q in a hepatitis B hyperendemic area. Oncogene 2006;25:3219-24. 25. Nishimura T, Nishida N, Itoh T, Komeda T, Fukuda Y, Ikai I, et al. Discrete breakpoint mapping and shortest region of overlap of chromosome arm 1q gain and 1p loss in human hepatocellular carcinoma detected by semiquantitative microsatellite analysis. Genes Chromosomes Cancer 2005;42:34-43. 26. Li SP, Wang HY, Li JQ, Zhang CQ, Feng QS, Huang P, et al. Genome-wide analyses on loss of heterozygosity in hepatocellular carcinoma in Southern China. J Hepatol 2001;34:840-9. 27. Kuroki T, Fujiwara Y, Tsuchiya E, Nakamori S, Imaoka S, Kanematsu T, et al. Accumulation of genetic changes during development and progression of hepatocellular carcinoma: loss of heterozygosity of chromosome arm 1p occurs at an early stage of hepatocarcinogenesis. Genes Chromosomes Cancer 1995;13:163-7. 28. O'Connell JR, Weeks DE. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998;63:259-66. 29. Sobel E, Papp JC, Lange K. Detection and integration of genotyping errors in statistical genetics. Am J Hum Genet 2002;70:496-508. 30. Chang HC, Yu MW, Lu CF, Chiu YH, Chen CJ. Risk factors associated with hepatitis C virus infection in Taiwanese government employees. Epidemiol Infect 2001;126:291-9. 31. Loeb KR, Jerome KR, Goddard J, Huang M, Cent A, Corey L. High-throughput quantitative analysis of hepatitis B virus DNA in serum using the TaqMan fluorogenic detection system. Hepatology 2000;32:626-9. 32. Ryncarz AJ, Goddard J, Wald A, Huang ML, Roizman B, Corey L. Development of a high-throughput quantitative assay for detecting herpes simplex virus DNA in clinical samples. J Clin Microbiol 1999;37:1941-7. 33. Kirschberg O, Schuttler C, Repp R, Schaefer S. A multiplex-PCR to identify hepatitis B virus-genotypes A-F. J Clin Virol 2004;29:39-43. 34. Kong X, Murphy K, Raj T, He C, White PS, Matise TC. A combined linkage-physical map of the human genome. Am J Hum Genet 2004;75:1143-8. 35. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 1996;58:1347-63. 36. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. Merlin--rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002;30:97-101. 37. S.A.G.E. Statistical Analysis for Genetic Epidemiology, Release 5.0. 2004. 38. Blackwelder WC, Elston RC. A comparison of sib-pair linkage tests for disease susceptibility loci. Genet Epidemiol 1985;2:85-97. 39. Strauch K. Parametric linkage analysis with automatic maximization of the disease model parameters. Am J Hum Genet Suppl 2003;73:A2624. 40. Whittemore AS, Tu IP. Simple, robust linkage tests for affected sibs. Am J Hum Genet 1998;62:1228-42. 41. Olson JM. A general conditional-logistic model for affected-relative-pair linkage studies. Am J Hum Genet 1999;65:1760-9. 42. Goddard KA, Witte JS, Suarez BK, Catalona WJ, Olson JM. Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4. Am J Hum Genet 2001;68:1197-206. 43. Hauser ER, Watanabe RM, Duren WL, Bass MP, Langefeld CD, Boehnke M. Ordered subset analysis in genetic linkage mapping of complex traits. Genet Epidemiol 2004;27:53-63. 44. Morton NE. The detection and estimation of linkage between the genes for elliptocytosis and the Rh blood type. Am J Hum Genet 1956;8:80-96. 45. Chen CJ, Yu MW, Liaw YF. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 1997;12:S294-308. 46. Gregory SG, Barlow KF, McLay KE, Kaul R, Swarbreck D, Dunham A, et al. The DNA sequence and biological annotation of human chromosome 1. Nature 2006;441:315-21. 47. Glidden DV, Liang KY, Chiu YF, Pulver AE. Multipoint affected sibpair linkage methods for localizing susceptibility genes of complex diseases. Genet Epidemiol 2003;24:107-17. 48. Hsu FC, Hetmanski JB, Li L, Markakis D, Jacobs K, Shugart YY. Comparison of significance level at the true location using two linkage approaches: LODPAL and GENEFINDER. BMC Genet 2003;4 Suppl 1:S46. 49. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995;11:241-7. 50. Hodge SE, Abreu PC, Greenberg DA. Magnitude of type I error when single-locus linkage analysis is maximized over models: a simulation study. Am J Hum Genet 1997;60:217-27. 51. Weeks DE, Lehner T, Squires-Wheeler E, Kaufmann C, Ott J. Measuring the inflation of the lod score due to its maximization over model parameter values in human linkage analysis. Genet Epidemiol 1990;7:237-43. 52. Simon D, Knowles BB, Weith A. Abnormalities of chromosome 1 and loss of heterozygosity on 1p in primary hepatomas. Oncogene 1991;6:765-70. 53. Yeh SH, Chen PJ, Chen HL, Lai MY, Wang CC, Chen DS. Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinomas. Cancer Res 1994;54:4188-92. 54. Chen HL, Chen YC, Chen DS. Chromosome 1p aberrations are frequent in human primary hepatocellular carcinoma. Cancer Genet Cytogenet 1996;86:102-6. 55. Marchio A, Meddeb M, Pineau P, Danglot G, Tiollais P, Bernheim A, et al. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer 1997;18:59-65. 56. Nagai H, Pineau P, Tiollais P, Buendia MA, Dejean A. Comprehensive allelotyping of human hepatocellular carcinoma. Oncogene 1997;14:2927-33. 57. Sakakura C, Hagiwara A, Taniguchi H, Yamaguchi T, Yamagishi H, Takahashi T, et al. Chromosomal aberrations in human hepatocellular carcinomas associated with hepatitis C virus infection detected by comparative genomic hybridization. Br J Cancer 1999;80:2034-9. 58. Sun M, Eshleman JR, Ferrell LD, Jacobs G, Sudilovsky EC, Tuthill R, et al. An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 region. Hepatology 2001;33:1415-24. 59. Leung TH, Wong N, Lai PB, Chan A, To KF, Liew CT, et al. Identification of four distinct regions of allelic imbalances on chromosome 1 by the combined comparative genomic hybridization and microsatellite analysis on hepatocellular carcinoma. Mod Pathol 2002;15:1213-20. 60. Ezaki T, Yanagisawa A, Ohta K, Aiso S, Watanabe M, Hibi T, et al. Deletion mapping on chromosome 1p in well-differentiated gastric cancer. Br J Cancer 1996;73:424-8. 61. Bieche I, Khodja A, Lidereau R. Deletion mapping of chromosomal region 1p32-pter in primary breast cancer. Genes Chromosomes Cancer 1999;24:255-63. 62. Shao JY, Huang XM, Yu XJ, Huang LX, Wu QL, Xia JC, et al. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma. Anticancer Res 2001;21:3021-9. 63. Bello MJ, de Campos JM, Vaquero J, Kusak ME, Sarasa JL, Rey JA. High-resolution analysis of chromosome arm 1p alterations in meningioma. Cancer Genet Cytogenet 2000;120:30-6. 64. Yang H, Wen YY, Zhao R, Lin YL, Fournier K, Yang HY, et al. DNA damage-induced protein 14-3-3 sigma inhibits protein kinase B/Akt activation and suppresses Akt-activated cancer. Cancer Res 2006;66:3096-105. 65. Qian YW, Wang YC, Hollingsworth RE, Jr., Jones D, Ling N, Lee EY. A retinoblastoma-binding protein related to a negative regulator of Ras in yeast. Nature 1993;364:648-52. 66. Neumann CA, Krause DS, Carman CV, Das S, Dubey DP, Abraham JL, et al. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature 2003;424:561-5. 67. Lapointe J, Lachance Y, Labrie Y, Labrie C. A p18 mutant defective in CDK6 binding in human breast cancer cells. Cancer Res 1996;56:4586-9. 68. Iwata N, Yamamoto H, Sasaki S, Itoh F, Suzuki H, Kikuchi T, et al. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma. Oncogene 2000;19:5298-302. 69. Canbay A, Higuchi H, Bronk SF, Taniai M, Sebo TJ, Gores GJ. Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. Gastroenterology 2002;123:1323-30. 70. Botstein D, Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet 2003;33 Suppl:228-37. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/34217 | - |
| dc.description.abstract | 背景：肝細胞癌為複雜性疾病，肝炎病毒感染和其他外生性或內生性因子間的交互作用為導致肝細胞癌的主要原因。肝細胞癌腫瘤組織染色體基因缺失的研究結果，已暗示在1號染色體短臂可能具有肝細胞癌的易感受性基因。材料與方法：我們在1號染色體短臂的區域選定37個微衛星標記，共涵蓋147.0 cM，以71家肝細胞癌多發病例家族為研究樣本，進行連鎖分析。藉由conditional logistic regression模式，分析可能導致基因座異質性的的變項對連鎖關係的影響。結果：當分別將發病年齡、性別、飲酒習慣，以及B型肝炎病毒的病毒量與基因型，做為變項放入模式中後，在1p染色體的三個區域發現有連鎖的情形：1p35.3 (位置59.0 cM，LOD score = 4.14，P<0.0001)，1p32.2-34.2 (位置79.8 cM，LOD score = 2.32，P = 0.0029)以及1p32.1 (位置92.5 cM，LOD score = 1.33，P = 0.0301)。當未放入變項時，則沒有與疾病連鎖的證據。分層分析顯示在1p32.2-34.2可能有肝細胞癌易感受性基因，尤其在有女性病例且沒有酗酒病例的22個家族(最大母數連鎖分析LOD值 = 3.26；最大無母數連鎖分析Z值 = 2.14，region-wide empirical P value = 0.0081)，和在病例病毒量較低的26個家族(最大母數連鎖分析LOD值 = 2.00；最大無母數連鎖分析Z值 = 2.34，region-wide empirical P value = 0.0108)。結論：未來應針對1p32.2-36.1的區域，進一步細部定位，以鑑定肝細胞癌易感受性基因。 | zh_TW |
| dc.description.abstract | Background: Hepatocellular carcinoma (HCC) is a complex disease with etiological heterogeneity, largely attributed to the interactions between hepatitis virus infection and many exogenous and/or endogenous factors. Chromosome 1p has been identified as a strong candidate region to contain HCC-susceptibility gene(s) on the basis of frequent allelic loss in sporadic HCCs. Materials and Methods: Linkage analysis was performed with a total of 37 microsatellite markers spanning 147.0 cM on chromosome 1p among 71 HCC multiplex families. We modeled locus heterogeneity among affected relative pairs with HCC by including covariates in the conditional logistic regression analysis. Results: By including age at onset, sex, lifetime habit of alcohol consumption, and/or hepatitis B viral load or genotype as covariates, we identified linkage signals in three chromosomal regions: 1p35.3 (LOD score= 4.14 at 59.0 cM, P<0.0001), 1p32.2-34.2 (LOD score=2.32 at 79.8 cM, P = 0.0029), and 1p32.1 (LOD score=1.33 at 92.5 cM, P = 0.0301). Without covariates, no evidence for disease linkage was found. Stratified analyses revealed that the 1p32.3-34.2 markers are likely to cosegregate with an HCC-susceptibility locus among families with female patients that had no alcoholic patients (maximum parametric LOD score = 3.26; nonparametric linkage Z score = 2.14, region-wide empirical P value = 0.0081) and among families with low HBV viral load (maximum parametric LOD score = 2.00; nonparametric linkage Z score = 2.34, region-wide empirical P value = 0.0108). Conclusion: Fine mapping studies to facilitate identification of HCC-susceptibility genes in the 1p32.2-36.1 regions are warranted. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-13T05:58:34Z (GMT). No. of bitstreams: 1 ntu-95-R93842006-1.pdf: 670129 bytes, checksum: 3c0dec525ebef41729a7a25cbf8af41f (MD5) Previous issue date: 2006 | en |
| dc.description.tableofcontents | Introduction(1)
Materials and Methods(3) Results(8) Discussion(11) References(15) Table 1(23) Table 2(24) Table 3(25) Table 4(26) Table 5(27) Table 6(28) Figure 1(29) Figure 2(30) Figure 3(31) Figure 4(32) | |
| dc.language.iso | en | |
| dc.subject | 基因定位 | zh_TW |
| dc.subject | 肝細胞癌 | zh_TW |
| dc.subject | 易感受基因座 | zh_TW |
| dc.subject | 一號染色體短臂 | zh_TW |
| dc.subject | 連鎖分析 | zh_TW |
| dc.subject | chromosome 1p | en |
| dc.subject | genetic mapping | en |
| dc.subject | linkage analysis | en |
| dc.subject | hepatocellular carcinoma | en |
| dc.subject | susceptibility locus | en |
| dc.title | 一號染色體短臂肝細胞癌易感受基因座之連鎖分析 | zh_TW |
| dc.title | Linkage Mapping Hepatocellular-Carcinoma Susceptibility Loci on Chromosome 1p | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 94-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 范盛娟,簡國龍,蔡世峰,許輝吉 | |
| dc.subject.keyword | 肝細胞癌,易感受基因座,一號染色體短臂,連鎖分析,基因定位, | zh_TW |
| dc.subject.keyword | hepatocellular carcinoma,susceptibility locus,chromosome 1p,linkage analysis,genetic mapping, | en |
| dc.relation.page | 32 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2006-06-28 | |
| dc.contributor.author-college | 公共衛生學院 | zh_TW |
| dc.contributor.author-dept | 流行病學研究所 | zh_TW |
| 顯示於系所單位： | 流行病學與預防醫學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-95-1.pdf 未授權公開取用 | 654.42 kB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。